Oral administration of ethyl acetate-soluble portion of Terminalia chebula conferring protection from streptozotocin-induced diabetic mellitus and its complications

Biological and Pharmaceutical Bulletin

Volumn 34, Issue 11, 2011, Pages 1702-1709

  Kim, Ji Hoon ^a   Hong, Chung Oui ^a   Koo, Yun Chang ^a   Kim, Su Jung ^a,b   Lee, Kwang Won ^a  

^a Korea University   (South Korea)

^b Daesang Corporation   (South Korea)

Author keywords

Advanced glycation end product; Glutathione; Lipid peroxidation; Streptozotocin; Terminalia chebula; Testicular dysfunction

Indexed keywords

ACETIC ACID ETHYL ESTER; ADVANCED GLYCATION END PRODUCT; ALCOHOL; AMINOGUANIDINE; GLUCOSE; LIPID; MALONALDEHYDE; STREPTOZOCIN; TERMINALIA CHEBULA EXTRACT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MEGADOSE; FRUIT; GLUCOSE BLOOD LEVEL; IN VIVO STUDY; KIDNEY DISEASE; LIPID BLOOD LEVEL; LIVER DISEASE; LIVER PROTECTION; LOW DRUG DOSE; MALE; NONHUMAN; PROTECTION; RAT; RENAL PROTECTION; SEMINIFEROUS TUBULE; STREPTOZOCIN DIABETES; THORACIC AORTA;

ADMINISTRATION, ORAL; ANIMALS; AORTA, THORACIC; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; FRUIT; GLYCOSYLATION END PRODUCTS, ADVANCED; HYPOGLYCEMIC AGENTS; KIDNEY; KIDNEY DISEASES; LIPIDS; LIVER; LIVER DISEASES; MALE; MALONDIALDEHYDE; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SEMINIFEROUS TUBULES; SOLUBILITY; TERMINALIA;

EID: 81455128723     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.34.1702     Document Type: Article

References (42)

1. Tan A. L. Y., Forbes J. M., Cooper M. E., Semin. Nephrol., 27, 130-143 (2007).
2. Ramakrishna V., Jailkhani R., Acta Diabetol., 45, 41-46 (2008).
3. Pazdro R., Burgess J. R., Mech. Ageing Dev., 131, 276-286 (2010).
4. Wu C.-H., Huang S.-M., Lin J.-A., Yen G.-C., Food Funct., 2, 224-234 (2011).
5. Brownlee M., Vlassara H., Kooney A., Ulrich P., Cerami A., Brownlee M., Science, 232, 1629-1632 (1986).
6. Corbett J. A., Tilton R. G., Chang K., Hasan K. S., Ido Y., Wang J. L., Sweetland M. A., Lancaster J. R. Jr., Williamson J. R., McDaniel M. L., Diabetes, 41, 552-556 (1992).
7. Lee H.-S., Koo Y.-C., Suh H.-J., Kim K.-Y., Lee K.-W., J. Ethnopharmacol., 131, 567-574 (2010).
8. Lee H.-S., Cho H.-Y., Park K.-W., Kim I.-H., Kim J.-T., Nam M.-H., Lee K.-W., Planta Med., 77, 1060-1067 (2011).
9. Kirtikar K. R., Basu B. D., "Indian Medicinal Plants," ed. by Kirtikar K. R., Basu B. D., Lalit Mohan Basu Publications, Allahabad, 1935, pp. 1020-1023.
10. Naik G. H., Priyadarsini K. I., Bhagirathi R. G., Mishra B., Mishra K. P., Banavalikar M. M., Mohan H., Phytother. Res., 19, 582-586 (2005).
11. Sato Y., Oketani H., Singyouchi K., Ohtsubo T., Kihara M., Shibata H., Higuti T., Biol. Pharm. Bull., 20, 401-404 (1997).
12. Saleem A., Husheem M., Härkönen P., Pihlaja K., J. Ethnopharmacol., 81, 327-336 (2002).
13. Murali Y. K., Anand P., Tandon V., Singh R., Chandra R., Murthy P. S., Exp. Clin. Endocrinol. Diabetes, 115, 641-646 (2007).
14. Lee H. S., Won N. H., Kim K. H., Lee H., Jun W., Lee K. W., Biol. Pharm. Bull., 28, 1639-1644 (2005).
15. Lee H.-S., Jung S.-H., Yun B.-S., Lee K.-W., Arch. Toxicol., 81, 211-218 (2007).
16. Buege J. A., Aust S. D., Methods Enzymol., 52, 302-310 (1978).
17. Koyuturk M., Tunali S., Bolkent S., Yanardag R., Biol. Trace Elem. Res., 104, 233-247 (2005).
18. El-Demerdash F. M., Yousef M. I., El-Naga N. I., Food Chem. Toxicol., 43, 57-63 (2005).
19. Goldberg R. B., Diabetes Care, 4, 561-572 (1981).
20. Rajagopal K., Sasikala K., Singapore Med. J., 49, 137-141 (2008).
21. Takasu N., Komiya I., Asawa T., Nagasawa Y., Yamada T., Diabetes, 40, 1141-1145 (1991).
22. Haugaard N., Physiol. Rev., 48, 311-373 (1968).
23. Acworth I. N., McCabe D. R., Maher T. J., "Antioxidants, Oxidants and Free Radicals," ed. by Baskin S., Salem H., Taylor and Francis, Washington, 1997, pp. 23-77.
24. Kaplowitz N., Aw T. Y., Ookhtens M., Annu. Rev. Pharmacol. Toxicol., 25, 715-744 (1985).
25. Ewis S. A., Abdel-Rahman M. S., J. Appl. Toxicol., 15, 387-390 (1995).
26. Loven D., Schedl H., Wilson H., Daabees T. T., Stegink L. D., Diekus M., Oberley L., Diabetes, 35, 503-507 (1986).
27. Nannipieri M., Lanfranchi A., Santerini D., Catalano C., van de Werve G., Ferrannini E., Nephron, 87, 50-57 (2000).
28. Biava C., Grossman A., West M., Lab. Invest., 15, 330-356 (1966).
29. Cameron D. F., Rountree J., Schultz R. E., Repetta D., Murray F. T., Am. J. Physiol. Endocrinol. Metab., 259, E881-E889 (1990).
30. Niven M. J., Hitman G. A., Badenoch D. F., Diabet. Med., 12, 921-924 (1995).
31. Basta G., Atherosclerosis, 196, 9-21 (2008).
32. Guimarães E. L. M., Empsen C., Geerts A., van Grunsven L. A., J. Hepatol., 52, 389-397 (2010).
33. Mallidis C., Agbaje I., Rogers D., Glenn J., McCullough S., Atkinson A. B., Steger K., Stitt A., McClure N., Hum. Reprod., 22, 2169-2177 (2007).
34. Mallidis C., Agbaje I. M., Rogers D. A., Glenn J. V., Pringle R., Atkinson A. B., Steger K., Stitt A. W., McClure N., Int. J. Androl., 32, 295-305 (2009).
35. Reagan-Shaw S., Nihal M., Ahmad N., FASEB J., 22, 659-661 (2008).
36. Juang L. J., Sheu S. J., Lin T. C., J. Sep. Sci., 27, 718-724 (2004).
37. Bazykina N. I., Nikolaevskii A. N., Filippenko T. A., Kaloerova V. G., Pharm. Chem.-USSR, 36, 46-49 (2002).
38. Montilla P. L., Vargas J. F., Túnez I. F., Muñoz de Agueda M. C., Valdelvira M. E., Cabrera E. S., Cabrera E. S., J. Pineal Res., 25, 94-100 (1998).
39. Tanaka Y., Shimizu H., Sato N., Mori M., Shimomura Y., Pharmacology, 50, 69-73 (1995).
40. Komabayashi T., Sawada H., Izawa T., Kogo H., Eur. J. Pharmacol., 298, 299-306 (1996).
41. Coskun O., Kanter M., Korkmaz A., Oter S., Pharm. Res., 51, 117-123 (2005).
42. Giardino I., Fard A. K., Hatchell D. L., Brownlee M., Diabetes, 47, 1114-1120 (1998).